Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
Prostate cancer diagnoses have reached a record high after campaigns urging men to come forward for checks. Official data ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...
The Brighterside of News on MSN
New drug combo cuts risk of death for men with prostate cancer by 40%
Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive ...
UroLift is a minimally invasive treatment for Benign Prostatic Hyperplasia, a condition that causes an enlarged prostate in ...
In a ground-breaking medical achievement, Nigeria has become the first country in West and Central Africa to successfully perform the UroLift procedure, a revolutionary treatment for benign prostate ...
News-Medical.Net on MSN
Breakthrough combo therapy lowers death risk in recurrent prostate cancer
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
WEDNESDAY, Oct. 22, 2025 (HealthDay News) — A powerful new drug combo has yielded a major breakthrough for men battling an ...
Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of ...
A Biden spokeswoman confirmed the former president finished several weeks of radiation therapy treatment Monday.
Adding the drug enzalutamide to standard hormone therapy reduced deaths by more than 40% in men with recurrent prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results